These are exciting times, with fresh news about research developments appearing every week.
Find out about the latest research news below and also visit our Breaking News in Research page.
Genetic factors that determine the severity of myotonic dystrophy type 1
Researchers involved in the OPTIMISTIC trial have published a scientific paper that identifies genetic factors that influence the severity of myotonic dystrophy type 1.
Read more-
Audentes update on neuromuscular programmes
07/08/2019Audentes Therapeutics has provided an update on its drugs in development for myotubular myopathy, Duchenne muscular dystrophy, myotonic dystrophy type 1 and Pompe disease.
-
Highlights from international myotonic dystrophy conference
22/07/2019Our Research Communications Manager, Dr Jenny Sharpe, recently attended the twelfth meeting of the International Myotonic Dystrophy Consortium (IDMC) in Gothenburg, Sweden.
-
Care recommendations for congenital myotonic dystrophy and myotonic dystrophy type 2 published
03/05/2019The first set of care recommendations for congenital and childhood-onset myotonic dystrophy type 1, and myotonic dystrophy type 2 have been published.
-
PREFER is looking for volunteers living with myotonic dystrophy or mitochondrial disease
20/02/2019As part of the IMI PREFER project, we’re working with Newcastle University to conduct focus groups for people with myotonic dystrophy type 1 or mitochondrial disease.
-
Cognitive behavioural therapy could be beneficial for people with myotonic dystrophy
23/07/2018A landmark trial has shown that cognitive behavioural therapy (CBT) can benefit people with myotonic dystrophy type 1.
-
Family hit £750,000 investment into myotonic dystrophy with new St Andrews project
19/06/2018A £35,000 investment into myotonic dystrophy at St Andrews University will ‘bring hope’ to those living with it, says Diana, Countess of Lindsay.
-
Understanding the prevalence of falls in myotonic dystrophy
08/05/2018A new research study using data from the UK myotonic dystrophy patient registry has been published. The registry is funded by MDUK and the MDSG.
-
Highlights of the 2018 Neuromuscular Translational Research Conference
30/04/2018The conference included talks and posters on a range of neuromuscular conditions. We were delighted to see lots of MDUK-funded researchers in attendance.
-
Positive results from myotonic dystrophy study
23/03/2018AMO Pharma recently presented data from its trial investigating a drug called tideglusib.
-
New therapeutic strategy developed for myotonic dystrophy
06/10/2017A new version of CRISPR/Cas9 has been used to remove the toxic RNA that causes myotonic dystrophy.